Heart transplantation as salvage treatment of intractable infective endocarditis

Clin Microbiol Infect. 2015 Apr;21(4):371.e1-4. doi: 10.1016/j.cmi.2014.11.027. Epub 2014 Dec 11.

Abstract

This study reports six consecutive patients who underwent heart transplantation as salvage treatment for endocarditis (Duke criteria) with extensive perivalvular lesions and end-stage heart failure. The median age was 45 years (range, 24 to 64), and the aortic valve was affected in all patients. Pathogens were Staphylococcus aureus (n = 2), Streptococcus pneumoniae (n = 2), Streptococcus agalactiae (n = 1), or not documented (n = 1). All patients survived, with no relapse, after a median follow-up of 24.5 months. The 10 patients with heart transplantation for endocarditis previously reported also survived (median follow-up, 27.5 months). Heart transplantation may be considered as salvage treatment in selected patients with intractable infective endocarditis.

Keywords: Heart transplantation; infective endocarditis; intracardiac fistula; periannular abscesses; salvage treatment.

MeSH terms

  • Adolescent
  • Adult
  • Endocarditis / microbiology
  • Endocarditis / surgery*
  • Female
  • Heart Transplantation / methods*
  • Humans
  • Male
  • Middle Aged
  • Salvage Therapy / methods*
  • Staphylococcus aureus / isolation & purification
  • Streptococcus agalactiae / isolation & purification
  • Streptococcus pneumoniae / isolation & purification
  • Treatment Outcome
  • Young Adult